What are the definitions, diagnostic criteria, causes, and fetal risks of fetal dolichocephaly and fetal brachycephaly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fetal Dolichocephaly and Brachycephaly: Definitions, Diagnostic Criteria, Causes, and Risks

Definitions and Diagnostic Criteria

Dolichocephaly is defined by a cephalic index (CI) ≤82%, while brachycephaly is defined by a CI ≥91%, where the cephalic index equals the biparietal diameter (BPD) divided by the occipitofrontal diameter (OFD) multiplied by 100 1, 2.

Measurement Standards:

  • Cephalic Index (CI): The ratio of the short axis to long axis of the fetal skull × 100
  • Normal range: CI of 74-83% (mean 78.3%) 2
  • Dolichocephaly: CI <74% or ≤82% 1, 2
  • Brachycephaly: CI >83% or ≥91% 1, 2

The cephalic index is particularly useful when standard BPD measurements may be unreliable due to head shape variations 2, 3.

Causes

Dolichocephaly:

The primary cause of fetal dolichocephaly is prolonged oligohydramnios, particularly in cases of preterm premature rupture of membranes (PPROM) 4.

  • Mechanical factors: Breech presentation is strongly associated with dolichocephaly, as fetuses in breech position are more likely to develop this head shape 4
  • Oligohydramnios duration: The longer the duration of oligohydramnios, the higher the likelihood of dolichocephaly development 4
  • Craniosynostosis: In rare cases, sagittal craniosynostosis can cause progressive dolichocephaly, with the CI decreasing by approximately 0.57 units per month in affected fetuses 5
  • Neurological disorders: Dolichocephaly may be associated with serious conditions like Miller-Dieker syndrome when accompanied by other neurological findings 6

Brachycephaly:

Brachycephaly in fetuses is most commonly associated with chromosomal abnormalities, particularly trisomy 21 (Down syndrome) 7.

  • Trisomy 21: Fetuses with Down syndrome demonstrate brachycephaly as early as 11-13 weeks gestation, with a significantly higher BPD to OFD ratio compared to chromosomally normal fetuses 7
  • Positional factors: In postnatal infants, brachycephaly is frequently caused by positional head deformity, though this is less relevant prenatally 1

Fetal Risks

Dolichocephaly Risks:

Fetuses with dolichocephaly in the cephalic presentation have an 83% risk of developing respiratory distress syndrome (RDS), compared to 42% in normocephalic fetuses 4.

  • Respiratory complications: The association with RDS is particularly strong in fetuses with PPROM and dolichocephaly 4
  • Motor development concerns: Preterm infants with dolichocephaly at 32-34 weeks postmenstrual age are more likely to require physical therapy services in early infancy 8
  • Delivery complications: Higher rates of malpresentation and surgical deliveries occur with dolichocephaly, particularly when associated with sagittal craniosynostosis 5
  • Important caveat: Despite the RDS association, dolichocephaly from oligohydramnios alone is NOT associated with poor overall neonatal prognosis or other adverse outcomes 4

Brachycephaly Risks:

Brachycephaly serves as an early marker for trisomy 21, detectable from the first trimester, and carries all associated risks of Down syndrome 7.

  • Chromosomal abnormalities: The presence of brachycephaly should prompt consideration of genetic testing, as it represents a structural manifestation of underlying chromosomal disorders 7
  • Aneuploidy screening: Brachycephaly was historically used as part of the second-trimester genetic sonogram to identify soft markers for aneuploidy 9

Clinical Implications

Diagnostic Approach:

When head shape variations are detected, the cephalic index should be calculated to distinguish between normal variation and pathological conditions. A CI >1 standard deviation from the mean (outside 74-83%) may significantly alter expected BPD measurements for gestational age, and alternative parameters like head circumference or transcerebellar diameter should be used for dating 2, 3.

Common Pitfalls:

  • Do not rely solely on BPD for gestational age estimation when dolichocephaly or brachycephaly is present, as this will lead to inaccurate dating 2, 3
  • Dolichocephaly from oligohydramnios should not be confused with the rare but serious finding of craniosynostosis—look for progressive worsening of the CI over serial scans 5
  • When brachycephaly is identified, particularly in the first trimester, consider offering genetic counseling and testing given the strong association with trisomy 21 7

References

Research

Estimating fetal age: effect of head shape on BPD.

AJR. American journal of roentgenology, 1981

Research

Dolichocephaly and oligohydramnios in preterm premature rupture of the membranes.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 1996

Research

Sonographic indicators of isolated fetal sagittal craniosynostosis during pregnancy.

Journal of medical imaging and radiation oncology, 2020

Research

Brachycephaly and frontal lobe hypoplasia in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2006

Guideline

acr appropriateness criteria® second and third trimester screening for fetal anomaly.

Journal of the American College of Radiology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.